Our Mission
PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
- You are here:
- Home »
- Blog »
- colon cancer »
- 10 Evidence-Based Integrative Therapies That May Enhance 5-FU Chemotherapy in Colorectal Cancer
10 Evidence-Based Integrative Therapies That May Enhance 5-FU Chemotherapy in Colorectal Cancer
10 Evidence-Based Integrative Therapies That May Enhance 5-FU Chemotherapy in Colorectal Cancer. Several evidence-based non-conventional therapies have been studied for their ability to enhance the anti-cancer effects of 5-fluorouracil (5-FU) in colorectal cancer. While most are not considered standard of care, many have preclinical evidence, and some have early clinical data suggesting synergy with 5-FU.
My name is Bernie Davis. I was recently diagnosed with colon cancer. See my diagnostic info below. As you can read from the discussion about my stage at diagnosis, while the percentage of risk of relapse is debatable, I do have a risk of relapse. A level of risk that I consider unacceptable.
Therefore, I have chosen to work with PeopleBeatingCancer.org to undergo integrative therapies to reduce my risk of relapse as well as reduce my risk of side effects.
In addition to the 10 natural compounds shown to reduce my risk of colon cancer, I also supplemented with Fenbendazole.
As of June of ’26, I have completed 12 rounds of Folfox chemotherapy while also undergoing the evidence-based, non-conventional therapies listed below.
The side effects I’ve experienced over the past six months are manageable. I’ve recently experienced real fatigue, but I think it’s less than what I read about other colon cancer patients experience.
I can’t report any long-term side effects. Nor can I report anything about a relapse. No news is good news at this point 😁
Are you a colorectal cancer survivor? Did you undergo any of the therapies below? What was your experience?
- Bernie Davis
- Colon Cancer Survivor
Enhance 5-FU Chemotherapy in Colorectal Cancer
✅ Summary in plain terms:
The report describes a 3.1 cm adenocarcinoma that has grown all the way through the intestinal wall to the abdominal lining, shows signs of spreading through blood vessels, lymph channels, and nerves, and has spread to 7 of 24 lymph nodes plus one additional tumor deposit. Fortunately, the surgeon removed it completely with negative margins. The official pathologic stage is pT4a pN2b (Stage IIIc).
Overall survival and recurrence statistics for Stage IIIC
- In older studies, when Stage III is subdivided by both T and N, Stage IIIC is the worst prognostic subgroup within Stage III. One classic analysis (ERCRC) estimated 5-year survival for Stage IIIC to be around 30 %(versus ~80 % for IIIA, ~60 % for IIIB) in patients treated with surgery alone. ACS Journals
- More recent population-level data suggest somewhat more favorable outcomes in the modern era, with intensification of therapy and better supportive care. PMC+1
- For example, the SEER “regional disease” category (which includes Stage III) reports a 5-year relative survival of ~73 %. American Cancer Society
- However, that “regional” group pools all Stage II and III—so the survival specifically for Stage IIIC is lower than the average for “regional” disease.
So, in a patient with Stage IIIC colon cancer and good margins, one might approximate a 5-year overall survival in the ballpark of 40-60 % (this is a rough, optimistic estimate in a favorable scenario). In more aggressive disease or with less optimal patient factors, it may be lower.
Enhance 5-FU Chemotherapy in Colorectal Cancer
1. Curcumin (Strongest Evidence)
Curcumin is one of the most extensively studied natural compounds in colorectal cancer.
Evidence
- Curcumin appears to sensitize colorectal cancer cells to 5-FU.
- May inhibit pathways associated with chemotherapy resistance (NF-κB, STAT3, Wnt/β-catenin).
- Several studies have demonstrated increased apoptosis and reduced tumor growth when combined with 5-FU.
Human Research
The phase IIa CUFOX trial combined curcumin with FOLFOX chemotherapy in metastatic colorectal cancer and found the combination was safe and showed encouraging survival outcomes.
Proposed Mechanisms
- Reduces inflammation
- Inhibits cancer stem cells
- Enhances apoptosis
- May reverse chemoresistance
2. Vitamin D
Vitamin D deficiency is common among colorectal cancer patients.
Evidence
- Higher vitamin D levels correlate with improved colorectal cancer survival.
- Laboratory studies suggest vitamin D enhances 5-FU sensitivity.
- May regulate tumor cell differentiation and immune function.
Clinical Data
The SUNSHINE trial found high-dose vitamin D supplementation improved progression-free survival in metastatic colorectal cancer patients receiving chemotherapy.
https://ascopost.com/News/59967
3. Omega-3 Fatty Acids (EPA/DHA)
Evidence
Omega-3 fatty acids may:
- Increase chemotherapy sensitivity
- Reduce inflammation
- Reduce cachexia and treatment-related weight loss
Research Findings
EPA appears to:
- Enhance apoptosis induced by 5-FU
- Improve drug uptake into tumor cells
- Reduce chemotherapy resistance mechanisms
Additional Benefits
- Preservation of lean body mass
- Reduced systemic inflammation
- Improved quality of life
4. Melatonin
Melatonin is far more than a sleep supplement.
Evidence
Research demonstrates that melatonin:
- Enhances 5-FU-induced apoptosis
- Protects normal tissues from oxidative damage
- May reduce chemotherapy side effects
Potential Mechanisms
- Antioxidant activity
- Immune modulation
- Mitochondrial regulation
- Suppression of angiogenesis
Several integrative oncology centers routinely include melatonin in supportive care protocols.
5. Medicinal Mushrooms
Particularly:
- Turkey Tail
- Maitake
- Reishi
Evidence
These mushrooms:
- Enhance NK cell activity
- Improve immune surveillance
- May help patients tolerate chemotherapy better
While direct synergy with 5-FU is less established than curcumin, they may improve host immune response during treatment.
6. Probiotics and Gut Microbiome Therapy
Emerging evidence suggests the gut microbiome influences chemotherapy response.
Evidence
Specific probiotic strains may:
- Reduce chemotherapy-induced diarrhea
- Improve gut barrier function
- Enhance anti-tumor immunity
Some studies suggest certain bacterial species increase responsiveness to fluoropyrimidine-based chemotherapy.
7. Green Tea Polyphenols (EGCG)
Evidence
EGCG has demonstrated:
- Enhanced 5-FU cytotoxicity
- Reduced colorectal cancer cell proliferation
- Increased apoptosis
Mechanisms
- Inhibition of EGFR signaling
- Anti-angiogenic effects
- Reduction of chemotherapy resistance pathways
Human evidence remains limited.
8. Exercise
Often overlooked as an adjunct therapy.
Evidence
Exercise:
- Improves chemotherapy completion rates
- Reduces inflammation
- Improves insulin sensitivity
- Enhances immune function
Some research suggests exercise-induced changes in tumor blood flow may improve chemotherapy delivery.
9. Modified Citrus Pectin
Evidence
Modified citrus pectin inhibits galectin-3, a protein involved in:
- Tumor growth
- Metastasis
- Chemotherapy resistance
Preclinical studies suggest potential synergy with conventional therapies, though colorectal cancer-specific clinical evidence remains limited.
10. Fasting-Mimicking Diets (FMD)
Evidence
Research from Valter Longo and colleagues suggests fasting or fasting-mimicking diets may:
- Increase cancer cell sensitivity to chemotherapy
- Protect healthy cells from chemotherapy damage
Early human studies are promising but remain investigational.
Therapies With Evidence Specifically for 5-FU Sensitization
If your goal is identifying therapies with the strongest evidence for directly enhancing 5-FU effectiveness, I would rank them:
- Curcumin
- Vitamin D
- Omega-3 Fatty Acids (EPA/DHA)
- Melatonin
- EGCG (Green Tea Extract)
- Gut Microbiome Optimization / Probiotics
Therapies Requiring Caution
These should not be used without oncology supervision:
- High-dose antioxidants during active chemotherapy
- High-dose vitamin C administered around infusion days
- Herbal mixtures with unknown ingredients
- Fenbendazole, ivermectin, or mebendazole during chemotherapy unless supervised by an oncologist familiar with potential interactions
| Rank | Therapy | Evidence Level |
|---|---|---|
| 1 | Curcumin | Human trial + strong mechanistic evidence |
| 2 | Vitamin D | Human trial + meta-analysis |
| 3 | Omega-3 (EPA/DHA) | Human studies + meta-analyses |
| 4 | Exercise | Strong human oncology evidence |
| 5 | Gut Microbiome Optimization | Emerging human evidence |
| 6 | Melatonin | Strong preclinical, limited clinical |
| 7 | Medicinal Mushrooms (PSK/Turkey Tail) | Moderate human evidence |
| 8 | EGCG | Primarily preclinical |
| 9 | Fasting-Mimicking Diet | Early human evidence |
Research to support the non-conventional therapies above-
Curcumin + 5-FU/FOLFOX
Phase IIa Clinical Trial (CUFOX)
Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer
PubMed:
PubMed Study
This randomized Phase IIa trial found that curcumin plus FOLFOX was safe and well tolerated in metastatic colorectal cancer patients.
Curcumin Targets Chemotherapy-Resistant Cells
Curcumin Targets FOLFOX-Surviving Colon Cancer Cells
PMC:
Full Text Study
Demonstrated that curcumin may eliminate chemotherapy-resistant colorectal cancer cells and cancer stem cells.
Curcumin and Cancer Stem Cells
PubMed:
PubMed Study
Curcumin enhanced the pro-apoptotic effects of FOLFOX and reduced cancer stem-cell markers.
Vitamin D + Chemotherapy
SUNSHINE Trial
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation
PubMed:
PubMed Study
High-dose vitamin D added to chemotherapy improved progression-free survival trends in metastatic colorectal cancer.
Review of Vitamin D in Colorectal Cancer
PMC:
Full Text Review
Excellent review of vitamin D mechanisms and clinical evidence in colorectal cancer.
Meta-analysis
PubMed:
PubMed Meta-analysis
Found a clinically meaningful survival benefit from vitamin D supplementation in colorectal cancer patients.
Omega-3 Fatty Acids (EPA/DHA)
Major Review
PubMed:
PubMed Review
Comprehensive review of omega-3 fatty acids as adjuvant therapy in colorectal cancer.
Omega-3 and Chemosensitivity
PubMed:
PubMed Study
Demonstrated increased chemosensitivity of colon cancer cells to 5-FU when exposed to omega-3 fatty acids.
EPA in Advanced CRC
PMC:
Full Text Study
Shows anti-tumor activity of EPA in advanced colorectal cancer models.
Systematic Review and Meta-analysis
PubMed:
Meta-analysis
Found improvements in inflammatory markers and potential treatment-related benefits in colorectal cancer patients.
Melatonin + 5-FU
Comprehensive Review
PubMed:
PubMed Search Results for Melatonin and Colorectal Cancer
Melatonin has demonstrated:
- Increased chemotherapy-induced apoptosis
- Reduced oxidative stress
- Improved chemotherapy tolerability
Most evidence remains preclinical, but the volume of supportive data is substantial.
Green Tea (EGCG) + 5-FU
Review
PubMed Search:
PubMed Search Results for EGCG and 5-FU Colorectal Cancer
Studies show:
- Increased apoptosis
- Reduced proliferation
- Potential reversal of chemotherapy resistance
Human data remain limited.
Probiotics / Gut Microbiome
Review
PubMed Search:
Gut Microbiome and Chemotherapy Response in Colorectal Cancer
Research suggests the microbiome may influence:
- Chemotherapy effectiveness
- Toxicity
- Immune response
- Progression-free survival
Medicinal Mushrooms
Turkey Tail (PSK)
PSK is actually approved as an adjuvant cancer therapy in Japan.
PubMed Search:
PSK Colorectal Cancer Research
Evidence suggests:
- Enhanced NK-cell activity
- Improved immune surveillance
- Potential survival benefits when combined with conventional therapy
Fasting / Fasting-Mimicking Diet
Key Research Group
Valter Longo
PubMed Search:
Fasting-Mimicking Diet and Chemotherapy Research
Research suggests fasting may:
- Increase cancer-cell sensitivity to chemotherapy
- Protect normal tissues from treatment toxicity
Human evidence is growing but remains investigational.
Enhance 5-FU Chemotherapy in Colorectal Cancer Enhance 5-FU Chemotherapy in Colorectal Cancer